Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
Apply
NEO-811
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step